Assenagon Asset Management’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-73,091
Closed -$648K 1400
2022
Q3
$648K Sell
73,091
-565,355
-89% -$7.11M ﹤0.01% 1050
2022
Q2
$8.07M Buy
638,446
+515,158
+418% +$6.56M 0.03% 429
2022
Q1
$2.33M Sell
123,288
-32,207
-21% -$820K 0.01% 780
2021
Q4
$5.46M Buy
155,495
+143,915
+1,243% +$4.68M 0.02% 487
2021
Q3
$424K Sell
11,580
-166,675
-94% -$6.56M ﹤0.01% 1090
2021
Q2
$7M Buy
178,255
+92,907
+109% +$2.68M 0.02% 411
2021
Q1
$2.41M Buy
+85,348
New +$2.72M 0.01% 671
2020
Q4
Sell
-137,476
Closed -$4.44M 1115
2020
Q3
$4.44M Buy
137,476
+67,049
+95% +$2.09M 0.02% 360
2020
Q2
$1.94M Buy
+70,427
New +$1.53M 0.01% 608

Other funds holding HCM

Assenagon Asset Management's HCM Position: Q4 2022 in Review

Assenagon Asset Management sold out of HUTCHMED (HCM) in Q4 2022, closing a stake of 73,091 shares — an estimated $648K sold.

Assenagon Asset Management first reported a position in HCM in Q2 2020 and held it in 9 quarters. The position peaked at $8.07M in Q2 2022. 84 funds tracked by Wall St. Rank hold HCM as of Q4 2022.

  • Assenagon Asset Management reported no remaining HUTCHMED position as of Q4 2022 after selling out during the quarter.
  • Assenagon Asset Management sold 73,091 HUTCHMED shares in Q4 2022, an estimated $648K.
  • Assenagon Asset Management first reported a position in HUTCHMED in Q2 2020 and held it in 9 quarters.
  • Assenagon Asset Management's HUTCHMED position peaked at $8.07M in Q2 2022.
  • 84 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2022.

Based on Assenagon Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.